Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02913404 · ClinicalTrials.gov registry record · NA

ACL-reconstruction vs ACL-reconstruction With EAT

A NA study of ACL, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT02913404: Completed NA study of ACL, sponsored by University of Pittsburgh.

NCT02913404 is a NA study of ACL that has completed, run by University of Pittsburgh. The registered enrollment target is 20 participants, below the 100-participant average among 6 other ACL trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02913404, a NA study of ACL, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to asses functional biomechanical outcomes and patient reported outcome measures following single bundle ACL reconstruction (ACL-R) compared to single bundle ACL reconstruction and extra articular tenodesis (ACL-R+EAT).

Primary Outcome

Outcome data includes: Joint contact path, functional joint space, anterior translation, varus-valgus rotation, and internal-external rotation will be obtained.

Conditions Studied

Interventions

  • PROCEDURE ACL Reconstruction
  • PROCEDURE ACL Recon. extra-articular-tenodesis

Study Locations (1)

Pennsylvania

  • University of Pittsburgh Biodynamics Lab - Pittsburgh

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-01
Est. Completion 2020-09
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT02913404 record still lists

NCT02913404 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 100-participant average among 6 other ACL trials with a reported enrollment target (80% lower).

The record links to 1 condition, with ACL appearing as the primary indexed condition, and to 2 interventions - of which ACL Reconstruction is the first listed.

NCT02913404 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02913404 about?

NCT02913404 is a clinical study titled "ACL-reconstruction vs ACL-reconstruction With EAT". The purpose of this study is to asses functional biomechanical outcomes and patient reported outcome measures following single bundle ACL reconstruction (ACL-R) compared to single bundle ACL reconstruction and extra articular tenodesis (ACL-R+EAT).

What is the current status of trial NCT02913404?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-01. Estimated completion is 2020-09.

What conditions does trial NCT02913404 study?

This clinical trial studies the following conditions: ACL.

What interventions are being tested in trial NCT02913404?

The interventions under investigation include: ACL Reconstruction (PROCEDURE), ACL Recon. extra-articular-tenodesis (PROCEDURE).

Who is sponsoring clinical trial NCT02913404?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02913404 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ACL

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02913404, the US trial registry maintained by the National Library of Medicine. NCT02913404 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.